Literature DB >> 27810784

The microRNA-635 suppresses tumorigenesis in non-small cell lung cancer.

Yan Zhang1, Zongwen Sun2, Yanqun Zhang3, Tian Fu1, Cun Liu4, Yongrui Liu1, Yong Lin5.   

Abstract

The microRNAs represent a class of noncoding RNAs with short length and play diverse roles in many biological processes. Despite tremendous effects have been devoted, the role of miR-635 in non-small cell lung cancer (NSCLC) remains elusive. Here we report a potential tumor suppressive function of miR-635 in NSCLC. By microRNA screening based on invasion assays, we identified series of functional miRNAs. The miR-635 was then identified as a potent inhibitor of cell invasion and differentially expressed in normal and cancerous tissues. We further confirmed that Ying Yang 1 (YY1) may be the direct target of miR-635 as miR-635 transfection can significantly decrease endogenous YY1 expression which can mimic the effect of siRNA-mediated YY1 knockdown. Meanwhile, both miR-635 transfection and YY1 silencing can attenuate NSCLC cell invasion. In addition, miR-635 transfection can also significantly inhibit the growth of xenograft tumors. Taken together, our results have suggested a novel tumor suppressive role for miR-635 in NSCLC.
Copyright © 2016 Elsevier Masson SAS. All rights reserved.

Entities:  

Keywords:  Invasion; NSCLC; YY1; miR-635

Mesh:

Substances:

Year:  2016        PMID: 27810784     DOI: 10.1016/j.biopha.2016.10.040

Source DB:  PubMed          Journal:  Biomed Pharmacother        ISSN: 0753-3322            Impact factor:   6.529


  10 in total

1.  Asiaticoside Suppresses Gastric Cancer Progression and Induces Endoplasmic Reticulum Stress through the miR-635/HMGA1 Axis.

Authors:  Chao Zhang; Xiaolin Ji; Zhenguang Chen; Zhichao Yao
Journal:  J Immunol Res       Date:  2022-06-02       Impact factor: 4.493

Review 2.  Spectrum of microRNAs and their target genes in cancer: intervention in diagnosis and therapy.

Authors:  Alti Dayakar; Kumar D Shanmukha; Suresh K Kalangi
Journal:  Mol Biol Rep       Date:  2022-01-15       Impact factor: 2.742

3.  YY1 directly suppresses MYCT1 leading to laryngeal tumorigenesis and progress.

Authors:  Si-Yao Qu; Yuan-Yuan Sun; Yun-Hui Li; Zhen-Ming Xu; Wei-Neng Fu
Journal:  Cancer Med       Date:  2017-05-09       Impact factor: 4.452

4.  MicroRNA-200c Inhibits Epithelial-Mesenchymal Transition by Targeting the BMI-1 Gene Through the Phospho-AKT Pathway in Endometrial Carcinoma Cells In Vitro.

Authors:  Fengling Li; Aihua Liang; Yan Lv; Guohong Liu; Aili Jiang; Peishu Liu
Journal:  Med Sci Monit       Date:  2017-10-28

5.  Long noncoding RNA PART1 promotes progression of non-small cell lung cancer cells via JAK-STAT signaling pathway.

Authors:  Dengyan Zhu; Yang Yu; Wei Wang; Kai Wu; Donglei Liu; Yang Yang; Chunyang Zhang; Yu Qi; Song Zhao
Journal:  Cancer Med       Date:  2019-08-22       Impact factor: 4.452

6.  Genome-Wide Characterization of RNA Editing Sites in Primary Gastric Adenocarcinoma through RNA-seq Data Analysis.

Authors:  Javad Behroozi; Shirin Shahbazi; Mohammad Reza Bakhtiarizadeh; Habibollah Mahmoodzadeh
Journal:  Int J Genomics       Date:  2020-12-18       Impact factor: 2.326

7.  Circular RNA circ_0090231 promotes atherosclerosis in vitro by enhancing NLR family pyrin domain containing 3-mediated pyroptosis of endothelial cells.

Authors:  Yishan Ge; Wenwu Liu; Wei Yin; Xuebin Wang; Jie Wang; Xiaoqing Zhu; Shengkai Xu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

8.  Circ_0092012 knockdown restrains non-small cell lung cancer progression by inhibiting cell malignant phenotype and immune escape through microRNA-635/programmed death ligand 1 axis.

Authors:  Jin Yan; Jian Zhu; Xiaoli Zhu; Hailing Liu; Guoping Chen
Journal:  Bioengineered       Date:  2022-05       Impact factor: 6.832

Review 9.  The biological implications of Yin Yang 1 in the hallmarks of cancer.

Authors:  Ian Timothy Sembiring Meliala; Rendy Hosea; Vivi Kasim; Shourong Wu
Journal:  Theranostics       Date:  2020-03-04       Impact factor: 11.556

10.  Overexpressed circRANBP17 acts as an oncogene to facilitate nasopharyngeal carcinoma via the miR-635/RUNX2 axis.

Authors:  Minghui Zhou; Puwen Zhang; Yulin Zhao; Rui Liu; Yujie Zhang
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.